Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Maybe we'll see the first of ongoing royalty licenses now as well

Maybe we'll see the first of ongoing royalty licenses now as well

posted on Sep 16, 2009 02:09PM

When Goerner came on board, he specifically revealed that those have always been on the table, but licensors always opted for the one-time payment deals instead. Perhaps that will change now, especially if, AS TPL IMPLIES, the price of licensing is going up.

Such a development may help stabilize the pps as it will provide recurring predictable revenue.

Share
New Message
Please login to post a reply